Healthcare
Providence Opens Neonatal IC Unit
Providence Holy Cross Medical Center in Mission Hills has opened an expanded and refurbished neonatal intensive care unit. The expansion, which cost nearly $9 million and was completed last month, added six beds to the 12 that comprised the original neonatal intensive care unit. “These babies are among our most vulnerable patients, and it takes […]
Atara Gets FDA Nod to Submit Data
Thousand Oaks-based Atara Biotherapeutics has reached an agreement with the federal Food and Drug Administration that clears the way for the company to submit to the agency clinical trial data for its drug to treat a rare blood cancer. Atara has developed a drug platform comprised of a type of immune cell known as a […]
A Tower Debuts
The opening of the Friese Family Tower at the Providence Cedars-Sinai Tarzana Medical Center is just around the corner. Ahead of the planned Oct. 1 opening, the tower held a friends and family preview on Aug. 26 to celebrate the tower, which has an expanded emergency department, 150 private patient rooms and advanced-care offerings including […]
MPulse’s Tech Has Medicaid in Mind
Since April 1, millions of low-income Americans have been thrown off the rolls of Medicaid, the government-sponsored health plan for the poor, as Covid-era protections expired and people were required to re-enroll or lose their coverage. And according to a study from the Kaiser Family Foundation, nearly three-fourths of those taken off the rolls so […]
Hospitals Get Top Ratings for Quality
Three San Fernando Valley-area hospitals have received five-star quality rating from the federal Centers for Medicare and Medicaid Services agency. The hospitals – Glendale Adventist Medical Center, Northridge Hospital Medical Center and Providence Holy Cross Medical Center in Mission Hills – placed in the top ranks of the agency’s annual quality-ratings survey released last month. […]
Amgen CEO Decries Federal Deliberations
Robert Bradway, chief executive of Thousand Oaks pharma giant Amgen Inc., has grown increasingly frustrated at the government’s unwillingness to come to terms with Amgen over its $27.8 billion acquisition deal of Irish pharma company Horizon Therapeutics. That deal, announced last December, hit a major stumbling block in May when the Federal Trade Commission filed […]